You have 9 free searches left this month | for more free features.

Carcinoma,%20Renal%20Cell

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumors Trial in France (Blood and tumor samples)

Recruiting
  • Neoplasms
  • Blood and tumor samples
  • Annecy, France
  • +5 more
Apr 8, 2022

T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

Not yet recruiting
  • T-cell Lymphoma
  • +10 more
  • Chicago, Illinois
    Rush University Medical Center
Oct 24, 2022

Hepatocellular Carcinoma Trial in Toronto (Pembrolizumab, Stereotactic Body Radiotherapy (SBRT))

Recruiting
  • Hepatocellular Carcinoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Dec 31, 2021

Advanced Solid Tumor, Gynecologic Cancer Trial in Worldwide (Lucitanib, Nivolumab)

Suspended
  • Advanced Solid Tumor
  • Gynecologic Cancer
  • Los Angeles, California
  • +26 more
Dec 16, 2022

Advanced Solid Tumor Trial in Hangzhou (KN052)

Recruiting
  • Advanced Solid Tumor
  • KN052
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jun 16, 2022

Chronic Lymphocytic Leukemia Trial in Portland (drug, procedure, biological, other)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2023

Pravastatin on Renal Function in Korean Dyslipidemic Type 2

Completed
  • Dyslipidemia Associated With Type II Diabetes Mellitus
  • Ansan, Korea, Republic of
  • +46 more
Oct 27, 2021

Hematopoietic Stem Cell Transplant Trial in Ann Arbor (Cardio-oncology program)

Not yet recruiting
  • Hematopoietic Stem Cell Transplant
  • Cardio-oncology program
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jul 6, 2023

Malignant Pleural Effusion Trial in Chandigarh (Doxycycline, Iodopovidine)

Active, not recruiting
  • Malignant Pleural Effusion
  • Doxycycline
  • Iodopovidine
  • Chandigarh, India
    Bronchoscopy suite, PGIMER
Mar 20, 2021

Response and Resistance to Pembrolizumab in Melanoma

Recruiting
  • Melanoma
  • Advanced Melanoma
  • Biopsy
  • Biospecimen Collection
  • San Francisco, California
    University of California, San Francisco
Nov 17, 2022

B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

Recruiting
  • B-Cell Lymphoid Malignancies
  • +2 more
  • Hematopoietic Stem Cells from HLA-compatible Related
  • Hematopoietic Stem Cells from HLA Unrelated
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
May 5, 2022

Sickle Cell Disease, Chronic Pain Trial (Quantitative sensory testing)

Not yet recruiting
  • Sickle Cell Disease
  • Chronic Pain
  • Quantitative sensory testing
  • (no location specified)
Nov 15, 2023

Hepatocellular Carcinoma Non-resectable Trial in France (Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Bordeaux, France
  • +5 more
Jun 12, 2023

End Stage Renal Disease Requiring Hemodialysis Trial in Worldwide (BAY2976217, Placebo)

Completed
  • End Stage Renal Disease Requiring Hemodialysis
  • Clovis, California
  • +68 more
Jan 20, 2023

End Stage Renal Disease Trial in Indianapolis (VFI using the FAST PV Technology)

Completed
  • End Stage Renal Disease
  • VFI using the FAST PV Technology
  • Indianapolis, Indiana
    Richard L. Roudebush VA Medical Center
Mar 7, 2022

Hepatic Impairment, Renal Impairment Trial in Sofia (Zibotentan)

Completed
  • Hepatic Impairment
  • Renal Impairment
  • Sofia, Bulgaria
    Research Site
Jan 26, 2022

Hand, Foot and Mouth Disease, Herpangina Trial in Chuxiong (low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated,

Recruiting
  • Hand, Foot and Mouth Disease
  • Herpangina
  • low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated
  • +3 more
  • Chuxiong, Yunnan, China
    Dayao County Center for Disease Control and Prevention
Sep 25, 2023

Mature B-cell Tumors Trial (Nemtabrutinib)

Not yet recruiting
  • Mature B-cell Neoplasms
  • (no location specified)
Jan 13, 2023

B-cell Non Hodgkin Lymphoma Trial in Hanzhou (CB dualCAR-NK19/70)

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • CB dualCAR-NK19/70
  • Hanzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 25, 2022

Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab Vedotin, Rituximab)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib, Polatuzumab Vedotin, Rituximab
  • Shanghai, Shanghai, China
    Zhongshan Hospital,Fudan University
Jul 10, 2023

Acute Lymphoblastic Leukemia, Non Hodgkin Lymphoma Trial (CD19-UCART)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • Non Hodgkin Lymphoma
  • CD19-UCART
  • (no location specified)
Jan 25, 2023

Volume Overload Trial in Cleveland (Oral Sodium Chloride, Placebo)

Active, not recruiting
  • Volume Overload
  • Oral Sodium Chloride
  • Placebo
  • Cleveland, Ohio
    Cleveland Clinic
Oct 1, 2022

Differentiated Thyroid Cancer Trial (Low iodine diet)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Low iodine diet
  • (no location specified)
Oct 25, 2022

Renal Anemia in Non-dialysis Chronic Kidney Disease Trial in Guangzhou (SAL-0951, Placebo)

Completed
  • Renal Anemia in Non-dialysis Chronic Kidney Disease
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Aug 23, 2023

Extensive Small Cell Lung Cancer Trial in China (TQB2450, Anlotinib, Etoposide)

Not yet recruiting
  • Extensive Small Cell Lung Cancer
  • Bengbu, Anhui, China
  • +25 more
Jan 18, 2020